Scientifically proven efficacy

MacuView is scientifically proven effective to improve the visual function in people with AMD and for the prevention of AMD. A comprehensive development program is being executed by Newtricious in co-operation with leading research institutions in the field of ophtolmology. Four clinical studies have been successfully completed in co-operation with the University Eye Clinic Academic Hospital Maastricht and the School for Nutrition, Toxicology and Metabolism (NUTRIM) at Maastricht, and Wageningen University & Research centre. A international multicenter study is on-going in the leading research institutions Tufts University in Boston (USA), Royal Eye Hospital in Manchester (GB) and Universitäts Augenklinik in Bonn (Germany). The clinical studies have demonstrated that MacuView is effective and well tolerated in long term daily consumption.

Click here for the results of the first clinical study.